FREE COMMUNICATION 17


15:15 - 16:45     CAPITAL SUITE 10/11

Free Communication Session 17 + Mini Lecture

Transplantation clinical

Chairs: Sanjin Racki, Rijeka, Croatia
            Søren Schwartz Sørensen, Copenhagen, Denmark

Mini lecture
Important trials in transplantation in the last 12 months
Bruno Watschinger, Vienna, Austria

FREE COMMUNICATIONS

SaO029
A RANDOMIZED STUDY COMPARING PARATHYROIDECTOMY VERSUS CINACALCET TO TREAT HYPERCALCEMIA IN KIDNEY ALLOGRAFT RECIPIENTS WITH PERSISTENT HYPERPARATHYROIDISM

Josep M. Cruzado1, Omar Taco1, Torregrosa Vicens2, Richard Mast3, Carol Polo4, Oriol Bestard1, Edoardo Melilli1, Jose Francos5, Joan Torras1, Carmen Gómez-Vaquero6, Garcia-Barrasa Arantxa5, Josep M. Grinyó1, Pablo Moreno5, 1Bellvitge Hosp, Nephrology, Barcelona, SPAIN, 2Hosp Clínic, Nephrology, Barcelona, SPAIN, 3Bellvitge Hosp, Radiology, Barcelona, SPAIN, 4IDIBELL, Nephrology, Barcelona, SPAIN, 5Bellvitge Hosp, Surgery, Barcelona, SPAIN, 6Bellvitge Hosp, Rheumatology, Barcelona, SPAIN.

SaO030
EFFICACY AND SAFETY OF LOW DOSE VERSUS FULL DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
Medhat Abdel Halim, Torki Al-Otaibi, Osama Gheith, Hany Adel, Ahmed Mosaad, Hassaneen Abo-Atteya, Zakaria Zakaria, Tarek Said, Prasad Nair, MRN Nampoory, Ibn Sina Hosp, Medical, Kuwait, KUWAIT.

SaO031
SERUM CALCIFICATION PROPENSITY PREDICTS MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS
Dag Olav Dahle1,2, Anders Åsberg1,3, Anders Hartmann1, Hallvard Holdaas1, Trond Geir Jenssen1,4,
Mauro Dionisi5, Andreas Pasch6, 1Oslo Univ Hosp, Dept Transplant Medicine, Oslo, NORWAY, 2Univ
Oslo, Medical Fac, Oslo, NORWAY, 3Univ Oslo, School Pharmacy, Oslo, NORWAY, 4UiT The Arctic
Univ Norway, Metabolic and Renal Research Group, Tromsø, NORWAY, 5Calcisco SA, Bern, Bern,
SWITZERLAND, 6Univ Hosp Bern, Dept Clinical Chemistry, Bern, SWITZERLAND.


SaO032
COMPUTER-ASSISTED INFLAMMATION ANALYSIS (CIA) OF KIDNEY-GRAFT BIOPSY: THE POLYGRAPH
OF ANTIBODY-MEDIATED REJECTION
Antoine Sicard1,2, Vannary Meas-Yedid3, Maud Rabeyrin4, Alice Koenig1,2, Stéphanie Ducreux5, Jean- Yves Scoazec4, Frederique Dijoud6, Lionel Badet7, Valerie Dubois5, Emmanuel Morelon2,8,1, Jean-Christophe Olivo-Marin3, Olivier Thaunat2,1,8, 1INSERM, U1111, Lyon, FRANCE, 2Hôp Edouard Herriot, Service Transplantation, Néphrologie et Immunologie Clinique, Lyon, FRANCE, 3Inst Pasteur, Unité d’Analyse d’Images Biologiques, CNRS URA 2582, Paris, FRANCE, 4Hôp Edouard Herriot, Service d’anatomopathologie, Lyon, FRANCE, 5Etablissement Français du Sang, EFS, Lyon, FRANCE, 6Groupement Hosp Est, Service anatomopathologie, Lyon, FRANCE, 7Hôp Edouard Herriot, Service urologie et transplantation rénale, Lyon, FRANCE, 8Univ Claude Bernard, Lyon 1, Lyon, FRANCE.

SaO033
FRACTURE RISK POST RENAL TRANSPLANTATION IN ENGLAND 2001-2013: A POPULATION
STUDY
Julia Arnold1, Irena Begaj2, David Bagnall2, Daniel Ray2, Adnan Sharif1, Charles Ferro1, 1Univ Hosp Birmingham NHS Foundation Trust, Dept Nephrology, Birmingham, UK, 2Univ Hosp Birmingham NHS
Foundation Trust, Dept Health Informatics, Birmingham, UK.

 

back to the timetable